NCT01801735

Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip

A Multicenter, Open-Label, Safety Study of Meloxicam SoluMatrix™ Capsules in Subjects With Osteoarthritis of the Knee or Hip

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 600 (actual)
• Sponsor: Iroko Pharmaceuticals, LLC · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DRUG	Meloxicam Test Capsules

Timeline

• Start date: 2013-03-01
• Primary completion: 2014-06-01
• Completion: 2014-08-01
• First posted: 2013-03-01
• Last updated: 2015-05-12
• Results posted: 2015-05-12

Locations

40 sites across 1 country: United States